Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants.

Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants.
复制标题

DOI:
10.1186/s40900-022-00349-7
复制
发表时间:
2022-04-25
影响因子:
--
通讯作者:
Audrey, Suzanne
Audrey, Suzanne
中科院分区:
其他
文献类型:
--
作者:
Fisher, Harriet;Chantler, Tracey;Finn, Adam;Kesten, Joanna;Hickman, Matthew;Letley, Louise;Mounier-Jack, Sandra;Thomas, Clare;Worthington, Katie;Yates, Julie;Audrey, Suzanne

文献摘要

被引文献

相似文献

以英国学校为基础的人类乳头瘤病毒(HPV)疫苗接种计划定期向所有12-13岁的年轻人提供,以预防影响宫颈、外阴、阴道、阴茎、肛门和口腔的癌症。一些人口群体的吸毒率较低,部分原因是年轻人的信息需求得不到满足。为了解决这些未得到满足的需求,我们报告了共同制作关于HPV疫苗的教育包的干预、规划和开发过程。我们使用了联合研究方法和“以人为本的方法”,包括以下迭代阶段:(I)整理和分析主要和次要证据,包括HPV疫苗宣传材料、访谈和讲习班;(Ii)制定指导原则;(Iii)根据行为改变轮和行为改变技术分类进行行为分析;(Iv)开发初步逻辑模型;(V)联合制作资源;以及(Vi)根据年轻人和关键线人的反馈改进资源。我们共同制作了教育,这是一个基于理论的教育包,旨在向年轻人提供HPV疫苗,以支持感染。年轻人和主要信息提供者确定了以下关键问题作为内容:(I)与HPV相关的信息;(Ii)疫苗如何工作;(Iii)HPV疫苗的安全性和副作用;(Iii)是否有资格参加HPV疫苗接种计划;以及(Iv)为年轻人接种HPV疫苗做好准备。为专业人员(如免疫接种护士、学校教职员工)编写了一份手册,介绍干预措施,并制作了PowerPoint演示文稿,其间穿插了五个短片,与年轻人和主要信息提供人共同制作了这本手册。根据反馈,对教育包的内容进行了改进,以增加对目标用户的接受度、参与度和说服力。与年轻人和主要信息者的接触是我们制定严格的、以理论为基础的干预措施的不可或缺的一部分,以满足年轻人对HPV疫苗接种计划的信息需求。通过与年轻人和主要线人密切合作,开发内容,最大限度地提高了一揽子计划的可接受性和说服力。目前正在进行一项执行研究,以审查如何在实践中实施教育一揽子计划,以及对接受HPV疫苗接种计划的影响。网上版载有补充材料,可在10.1186/s40900-022-00349-7查阅。在英国,12-13岁的年轻人在学校接种人乳头瘤病毒(HPV)疫苗,以预防某些类型的癌症。一些年轻人有一些悬而未决的问题,可能会阻止他们接种疫苗。我们报告了我们如何与年轻人和专业人士一起编写关于HPV疫苗的课程,以改进有关HPV疫苗的信息提供方式。首先,我们回顾了为年轻人设计的研究研究和HPV疫苗信息材料。然后,我们进行了访谈和研讨会,询问最好的授课方式和最重要的信息。我们与创意设计师合作制作电影和动画。最后,我们询问了年轻人和专业人士对课程材料的反馈意见。这节课包括一个PowerPoint演示文稿,其中有五部电影,并为领导课程的人提供指导。年轻人确定了关于HPV疫苗将涵盖的关键主题。这些信息包括疫苗如何起作用,以及如何改善年轻人在学校接种HPV疫苗的体验。我们对课程中的信息进行了修改,以确保它与年轻人相关。我们现在正在进行一项研究,看看这门课上得有多好,以及它是否可以帮助更多的年轻人接种HPV疫苗,如果他们想要的话。网上版载有补充材料,可在10.1186/s40900-022-00349-7查阅。
The English schools-based human papillomavirus (HPV) vaccination programme is routinely offered to all young people aged 12–13 years, to prevent cancers affecting the cervix, vulva, vagina, penis, anus and mouth. Lower uptake among some population groups has been identified, in part, because of unmet information needs among young people. To address these unmet needs we report intervention planning and development processes to co-produce an educational package about the HPV vaccine. We used co-production research methodologies and the ‘person-based approach’ involving the following iterative stages: (i) collating and analysing primary and secondary evidence, including HPV vaccine communication materials, interviews and workshops; (ii) developing guiding principles; (iii) undertaking a behavioural analysis informed by the Behaviour Change Wheel and the Behaviour Change Technique taxonomy; (iv) development of a preliminary logic model; (v) co-production of resources, and; (vi) refinement of resources informed by feedback from young people and key informants. We co-produced EDUCATE, a theory-based educational package, that is designed to be delivered to young people prior to being offered the HPV vaccine to support uptake. Young people and key informants identified the following key issues to include as content: (i) HPV-related information; (ii) how vaccines work; (iii) safety and side-effects of the HPV vaccine; (iii) eligibility for the HPV vaccination programme, and; (iv) preparation of young people to receive the HPV vaccine. A manual for professionals (e.g. immunisation nurses, school staff) delivering the intervention and a PowerPoint presentation, interspersed with five short films, were co-produced with young people and key informants. Following feedback, the content of the EDUCATE package was refined to increase acceptability, engagement, and persuasiveness to the target users. Engagement with young people and key informants was integral to the development of our rigorously developed, theory-based intervention to address young people’s information needs about the HPV vaccination programme. The acceptability and persuasiveness of the package has been maximised by working closely with young people and key informants to develop the content. An implementation study to examine how the EDUCATE package is implemented in practice and the impact on uptake of the HPV vaccination programme is underway. The online version contains supplementary material available at 10.1186/s40900-022-00349-7. In England, young people are offered the human papillomavirus (HPV) vaccine in schools at age 12–13 years to prevent some types of cancer. Some young people have unanswered questions which may stop them getting vaccinated. We report how we developed a lesson about the HPV vaccine jointly with young people and professionals to improve how information about the HPV vaccine is given. First, we reviewed research studies and HPV vaccine information materials designed for young people. Then, we carried out interviews and workshops to ask about the best way to give a lesson and the most important information to include. We worked with creative designers to produce films and animations. Finally, we asked young people and professionals for feedback on the lesson materials. The lesson includes a PowerPoint presentation with five films and guidance for people leading the session. Key topics about the HPV vaccine to be covered were identified by young people. These included information about how vaccines work and ways to improve young people’s experience of having the HPV vaccine at school. We made changes to the information in the lesson to ensure that it was relevant to young people. We are now carrying out a study to find out how well the lesson is given and whether it can help more young people get the HPV vaccine if they want it. The online version contains supplementary material available at 10.1186/s40900-022-00349-7.